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Strengths and limitations of this study
 ► This is the first study of its kind to examine diabe-
tes intermediate clinical outcomes and programme 
costs in a complex humanitarian setting in sub- 
Saharan Africa.
 ► Using routine clinical and programmatic data col-
lected in a protracted conflict setting, we estimated 
the effect of insecurity and related programmatic 
changes on diabetes intermediate clinical outcomes, 
which, to our knowledge, has not been addressed in 
the literature to date.
 ► The study was limited by the relatively small sample 
size and lack of control group for comparison.
 ► The costing analysis was descriptive and based on 
aggregate data and so neither the cost- effectiveness 
of the programme nor patient- level costs could be 
determined.
AbStrACt
Objective We aimed to evaluate an Integrated Diabetic 
Clinic within a Hospital Outpatient Department (IDC- 
OPD) in a complex humanitarian setting in North Kivu, 
Democratic Republic of Congo. Specific objectives 
were to: (1) analyse diabetes intermediate clinical and 
programmatic outcomes (blood pressure (BP)/glycaemic 
control, visit volume and frequency); (2) explore the 
association of key insecurity and related programmatic 
events with these outcomes; and (3) describe incremental 
IDC- OPD programme costs.
Design Retrospective cohort analysis of routine 
programmatic data collected from January 2014 
to February 2017; analysis of programme costs for 
2014/2015.
Setting Outpatient diabetes programme in Mweso 
hospital, supported by Médecins sans Frontières, in North 
Kivu, Demographic Republic of Congo.
Participants Diabetes patients attending IDC- OPD.
Outcome measures Intermediate clinical and 
programmatic outcome trends (BP/ glycaemic control; visit 
volume/frequency); incremental programme costs.
results Of 243 diabetes patients, 44.6% were women, 
median age was 45 (IQR 32–56); 51.4% were classified 
type 2. On introduction of IDC- OPD, glucose control 
improved and patient volume and visit interval increased. 
During insecurity, control rates were initially maintained 
by a nurse- provided, scaled- back service, while patient 
volume and visit interval decreased. Following service 
suspension due to drug stock- outs, patients were less 
likely to achieve control, improving on service resumption. 
Total costs decreased 16% from 2014 (€36 573) to 2015 
(€30 861). Annual cost per patient dropped from €475 in 
2014 to €214 in 2015 due to reduced supply costs and 
increased patient numbers.
Conclusions In a chronic conflict setting, we documented 
that control of diabetes intermediate outcomes was 
achievable during stable periods. During insecure periods, 
a simplified, nurse- led model maintained control rates until 
drug stock- outs occurred. Incremental per patient annual 
costs were lower than chronic HIV care costs in low- 
income settings. Future operational research should define 
a simplified diabetes care package including emergency 
preparedness.
bACkgrOunD
Over the last 40 years, diabetes prevalence 
has increased sharply worldwide, particu-
larly in low and middle- income countries 
(LMICs).1 However, data on the burden and 
needs related to diabetes and other non- 
communicable diseases (NCDs) are scarce 
from conflict- affected countries, particularly 
those in sub- Saharan Africa.1 2 Humanitarian 
actors have been slow to prioritise diabetes 
treatment in disaster and post- conflict settings 
despite reporting increasing presentations of 
diabetic patients within their programmes.3–6 
This is due to lack of knowledge on local 
diabetes epidemiology; limited research on 
diabetes management or outcomes in crisis 
settings; a lack of programmatic and policy 
guidance or tools to support diabetes care in 
such settings; prioritisation of other health 
needs; and also a perception that diabetes 
care is complex and expensive.2 3 6–8
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The humanitarian situation in Democratic Republic 
of Congo (DRC) is considered one of the most complex 
and challenging worldwide. Prolonged conflict over 
two decades has resulted in over 5 million deaths, over 
4.5 million internally displaced people, the exodus of 
over 800 000 refugees and ongoing political and social 
instability.9 10 The health system, weakened by prolonged 
conflict, is challenged by competing health needs in a 
country ranked 176 of 189 on the human development 
index despite holding rich natural resources.11
On this backdrop, diabetes prevalence is increasing, 
currently estimated at 4.0%–5.4%.12–14 While some 
factors implicated in the global rise in diabetes preva-
lence hold true in DRC (demographic change, urban-
isation, changing diets and so on) chronic conflict and 
political instability add additional complexity. Recent 
reviews and ethnographic evidence point to a link 
between chronic food insecurity, childhood malnutri-
tion and diabetes.13 15 16 In DRC, 43% of children under 
5 years are chronically malnourished and levels of food 
insecurity have risen sharply, with millions subsisting 
on World Food Programme rations.17 Recent evidence 
also supports an association between chronic perceived 
stress and diabetes onset, while patients with diabetes 
in humanitarian settings focus on suffering and loss as 
a cause of their illness.16 18 Furthermore, in humani-
tarian crises, people with diabetes are at increased risk of 
complications and death due to treatment interruption 
and precarious access to food and water.2 6
Médecins sans Frontières (MSF), a medical humani-
tarian organisation, has supported healthcare delivery 
in Mweso, North Kivu, in collaboration with the Ministry 
of Health since 2008. North Kivu is a rural, impover-
ished area bordering Rwanda with an estimated popula-
tion of 365 000. It remains a flash point in the ongoing 
conflict between shifting rebel groups and government 
forces, which has been characterised by brutal violence 
against civilians and destruction of lives and livelihoods. 
Outbreaks of violence since 2016 have resulted in recur-
rent waves of population displacement; North Kivu alone 
hosts 17 internally displaced person camps. MSF supports 
health services in 4 out of 23 primary healthcare clinics 
and in Mweso hospital within Masisi District. Mweso 
hospital serves a catchment area of ~145 000 people, with 
about 65 000 recipients of care living in the immediate 
vicinity of the hospital.
While a national diabetes programme exists in DRC, 
available diabetes care is concentrated at hospital level 
in major cities.19 In response to growing patient and 
provider needs in Mweso, MSF implemented a hospital- 
outpatient based diabetes programme in March 2015, 
the Integrated Diabetic Clinic within a Hospital Outpa-
tient Department (IDC- OPD) in place of the ad hoc care 
previously undertaken. The IDC- OPD was integrated at 
the clinical level into usual outpatient activities, with pre- 
existing staff trained to provide this additional service.20 
The programme comprised a nurse- led, multidisci-
plinary model, using locally adapted clinical guidelines, 
patient counselling materials and data collection tools, 
accompanied by 3 days of specialist training.21 The clinic 
team included: a nurse supervisor, nursing assistant, two 
doctors, a nutritionist, and education and psychosocial 
support officers. Diabetes was diagnosed according to 
WHO guidelines using repeated fasting capillary glucose. 
Most patients were identified as diabetic and enrolled 
after acute hospital presentation, while some were iden-
tified via the Mweso outpatient department or referring 
primary care clinics.
Patients received a detailed enrolment assessment, 
monthly nurse- led follow- up and 6- monthly medical 
review. The programme included context- adapted dietary 
advice (accounting for locally available and affordable 
foods and customs) and psychosocial support, including 
clinician- moderated peer support groups and involve-
ment of family or friends as treatment supporters. The 
psychosocial aspects of patients and providers managing 
diabetes are discussed in a related paper, with major 
themes from the patient perspective including the diffi-
culty adhering to the recommended diet and barriers to 
clinic access during outbreaks of violence.22 Each patient 
was given a clinic- held patient file and patient- held 
passport to facilitate safe passage when armed groups 
impeded their travel. Clinical guidelines were adapted 
from MSF, WHO and other international guidance.23 
Patient educational tools (disease and diet education leaf-
lets) were adapted from Santé Diabète,24 a Malian Non- 
Governmental Organisation, and generic medications, 
included on MSF’s essential drugs list, were prescribed. 
In the absence of home glucose monitoring, insulin doses 
were adjusted using single fasting capillary blood glucose 
(FBG) readings and patients’ reported symptoms of hypo-
glycaemia or hyperglycaemia. Insulin- dependent patients 
were prescribed human insulin, delivered via needle and 
syringe, and advised to store this at home in a clay pot, 
recommended as a safe alternative to refrigeration in 
similar contexts.25
In early 2016, outbreaks of armed violence restricted 
movement of patients and supplies. Direct attacks on MSF 
staff and facilities, including an armed robbery and abduc-
tions, led to withdrawal of the international staff from 
Mweso and temporary scaling back of the programme, 
with local nursing staff dispensing medications to any 
patients reaching the clinic. Later, the programme was 
suspended for a period of 6 weeks when supply routes 
were entirely blocked and drug stocks were exhausted.
A mixed- methods evaluation of the Mweso IDC- OPD 
programme was undertaken by MSF and included a qual-
itative evaluation exploring patient and provider clinical 
and psychosocial challenges, presented elsewhere22; and 
a retrospective review of quantitative programmatic data 
and cost data collected as part of routine care in a chronic 
conflict zone, which is reported here. The overall aim 
of this paper was to evaluate an IDC- OPD in a complex 
humanitarian setting in North Kivu in DRC. The specific 
objectives were to: (1) analyse diabetes intermediate 
clinical and programmatic outcomes (blood pressure 
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Table 1 Study periods for evaluation of IDC- OPD programme, Mweso, DRC
Study period Description Dates
Training 1 (T1) Ad hoc diabetes service following basic staff training 01/01/2014 to 14/03/2015
Training 2 (T2) IDC- OPD implemented following formal staff training 15/03/2015 to 14/12/2015
Suspend 1 (S1) Nurse- provided care without medical supervision; monthly 
drug refills provided until buffer stocks were exhausted
15/12/2015 to 31/01/2016
Suspend 2 (S2) No clinical supervision or drugs were provided 01/02/2016 to 14/04/2016
Resume 1 (R1) The service was resumed without medical supervision or 
quality control
15/04/2016 to 31/08/2016
Resume 2 (R2) Full service resumed until end of data collection period 01/09/2016 to 09/02/2017
DRC, Democratic Republic of Congo; IDC- OPD, Integrated Diabetic Clinic within a Hospital Outpatient Department.
(BP)/glycaemic control, visit frequency and volume); 
(2) explore the association of key insecurity and related 
programmatic events with these outcomes; and (3) 
describe incremental IDC- OPD programme costs.
MethODS
It has been acknowledged that traditional experimental 
and evaluation methods may be unfeasible, inappropriate 
or even unethical to apply in humanitarian settings.26 
Therefore, we have used a pragmatic approach to util-
ising programmatic data, with an open cohort design. 
For the outcome analysis, we conducted a retrospec-
tive analysis of routine data of enrolled adults aged ≥18 
years from January 2014 to February 2017, examining 
trends in diabetes outcomes and their association with 
key programmatic events. The study period was divided 
into five phases, defined by programmatic changes or 
periods of heightened insecurity (which impacted service 
delivery due to staff evacuation, supply chain interrup-
tion and reduced patient access). Period T1 refers to ad 
hoc care delivered before introduction of the IDC- OPD 
programme (T2). Security incidents in December 2015 
prompted a period of service suspension (nurse- only care, 
with drug pick- ups, glucose testing and minimal treat-
ment adjustments) (S1). Complete suspension followed 
once drug stocks were exhausted (S2). Limited service 
resumed in April (R1) until full service recommenced 
from September 2016 (R2) (table 1).
Data
Patients were given a unique identification number on 
enrolment. Data were recorded in paper- based clinic- 
held files by clinical staff and transferred to an electronic 
database by a trained data entry operator on a weekly 
basis. Missing data were discussed with the nurse manager 
and gaps were filled during follow- up clinical visits. Single 
data entry was performed on a password- protected Micro-
soft Excel software application specifically developed by 
MSF for this programme. Anonymised exports were trans-
ferred to the study team on a monthly basis.
Demographic data on patients’ age, gender, occu-
pation and village of residence were recorded on 
enrolment. Cardiovascular risk factors (smoking status, 
current alcohol use), family history of diabetes, year of 
diabetes diagnosis and self- reported history of childhood 
malnutrition and/or tuberculosis were recorded. Clin-
ical parameters: body mass index (BMI), BP measured 
by manual sphygmomanometer according to local MSF 
protocols,21 FBG; prescribed diabetes drugs (insulin 
and/or oral hypoglycaemic drugs (OHGs)); and diabetes 
classification (type I, type II or other) were recorded at 
each clinical encounter. Medical review at enrolment and 
6 monthly thereafter was recorded, including biochemical 
markers (serum creatinine) and examination for compli-
cations (visual acuity, cataract, proteinuria, foot check). 
Numbers of deaths, transfers out of the area and delays in 
attendance were also documented. The key intermediate 
clinical outcome and programme measures used in the 
analysis are shown in table 2.
Analysis
Basic demographics were analysed using mean and median 
and were presented with IQRs. We assessed the relation-
ship of different study periods with the frequency of visits 
and the impact of study periods on intermediate clinical 
outcomes, that is, per visit attainment of BP (<140/90 mm 
Hg) and glycaemic (>4.2 and ≤8.3 mmol/L) targets.
To estimate the effect of a period change, we calcu-
lated the OR of the odds of having the biomarker under 
control in a visit in the new period (t) over the odds of 
having the biomarker controlled in a visit in the previous 
period (t-1): ORt=Oddst/Oddst–1. If ORt >1, this meant 
that the chances of the biomarker being under control 
in a visit in period t was greater than the chances of the 
biomarker being under control in a visit in the previous 
period (t–1) (but not necessarily than other periods, t–2, 
t–3 and so on). Likewise, ORt <1 implied a reduction in 
the chances of having the biomarker under control in 
a visit during period t compared with a visit during the 
previous period (t–1). To estimate these OR, we ran a 
logistic model with period as a categorical variable, suit-
ably coded and adjusted for sex, age (and square and cube 
terms) and number of visits of the patient (and square 
term). The models were stratified by whether the patient 
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Table 2 Outcome measures used to determine effect of 
different programme periods on programme delivery and 
intermediate clinical outcomes
Category Variable
Intermediate 
clinical 
outcomes
Proportion of visits per month where 
patients’ BP is at target (<140/90 mm Hg).
Proportion of visits per month where 
patients’ blood glucose is at target 
(>4.2 and ≤8.3 mmol/L).
Number and 
frequency of 
visits
Number of visits per month.
Number of patients seen per month.
Average visits per patient per month.
Average days from previous visit.
Missing data for BP / glycaemia per visit.
BP, blood pressure.
was prescribed insulin (±oral hypoglycaemic agents) at 
the previous visit.
Missing data
Our main analysis used only complete data; records 
with missing data were excluded. Few outcome variable 
data were missing: <3% in BP control (most of it in the 
pretraining period) and <0.3% for glycaemic control 
(online supplement SM1). There were no missing data 
for date of visit, sex or age.
Costing data and analysis
For the descriptive, incremental cost analysis, we took a 
health services perspective. Information related to the 
nature, location and mode of delivery of the NCD services 
was collected during a field visit in December 2015 by the 
study team and was supplemented by informal interviews 
with clinical and administrative staff. A data analysis tool 
was designed to collate the relevant financial costs for 
the study period 2014–2015 from routine programme 
documents and standard MSF tools including budget, 
human resources, drug consumption monitoring, logis-
tics/supply tools, clinic records and programme reports. 
For salary costs, we included the incremental costs of an 
MSF- employed medical doctor and nurse and an Ministry 
of Health (MOH)- employed nurse (with salary supple-
ment paid by MSF), dedicating 1 day, two psychosocial 
workers dedicating 1 hour and a nutritionist dedicating 
30 minutes per week to the IDC- OPD service (based on 22 
working days per month). Hence, most costs were related 
to drugs, equipment, disposables and stationary. Key cost 
items were grouped into: (1) medicine, (2) supplies and 
(3) staff time. Monthly resource use and unit cost data 
were recorded and annualised (online supplement SM2); 
annual total cost, cost per visit and cost per patient were 
reported in Euro (€) for 2014 before formal implemen-
tation of the IDC- OPD programme and for 2015 during 
full implementation.
Patient and public involvement
Patients were not involved in the design or conduct of 
this study.
reSultS
Between 1 January 2014 and 9 February 2017, 243 
patients were enrolled in the IDC- OPD programme 
(online supplement SM3). Median age was 45 years (IQR 
32–56); 44.4% of the cohort was female. For adults ≥18 
years (n=219), mean BMI was 21.3 kg/m2 and 31.1% were 
underweight (BMI <18.5 kg/m2). On enrolment, 8.2% 
were current smokers; 24.8% reported recent alcohol 
intake; self- reported medical history included: 9.1% 
hypertension, 2.2% cardiovascular disease, 2.7% tuber-
culosis and 8.7% malnutrition. Half were classified clini-
cally as type II diabetic (51%; n=125); 26% (n=62) as type 
I; and 23% (n=56) were either unclassified or classed as 
‘other’ (online supplement SM3).
trends in outcomes and impact of programmatic events
Numbers of visits and appointment intervals increased 
after the introduction of the systematic approach to 
diabetes care, which included monthly review appoint-
ments for stable patients (T2) (figure 1; online supple-
ment SM4). During the period of scaled back service 
(S1), visit numbers initially climbed while the visit interval 
decreased, which may reflect increased visit frequency 
due to short- term drug supplies. Once drug buffer stock 
was exhausted, visit numbers dropped off sharply. Patients 
may have avoided or were prevented from attending due 
to security conditions.
BP control was consistently better than glycaemic 
control (of note, patients without diagnosed hypertension 
were included in the analysis) (figure 2). By period T2, 
~80% of visits achieved BP and 60% achieved glycaemic 
control. There was a notable drop in control of both 
parameters during programme suspension with a gradual 
improvement on resumption. BP control was consistently 
better, while glycaemic control was consistently worse, 
in patients prescribed insulin (±OHGs) compared with 
those prescribed OHGs alone (online supplement SM5), 
which may be because the former group contained rela-
tively young type I and malnutrition- related diabetics.
The results of the OR calculations were unexpected. 
Odds of attaining BP control appeared to worsen following 
implementation of the formal IDC- OPD programme (T2 
vs T1), while odds of attaining glucose control improved, 
perhaps because care was initially focused on glucose 
control (online supplement SM6). On scaling back 
the service (S1), control of both parameters seemed to 
improve, possibly because the service itself or the subset 
of patients reaching it during the insecure period were 
somehow different. Once medications supplies were 
exhausted (S2), control of both parameters seemed to 
worsen, but control was regained on service resumption. 
Stratifying by insulin prescription showed similar results 
(online supplement SM5).
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Figure 1 Average number of days from previous visit per month for Mweso IDC- OPD service. IDC- OPD, Integrated Diabetic 
Clinic within a Hospital Outpatient Department.
Costs of providing diabetes care
The total costs of diabetes care in 2014 and 2015 were 
~€37 000 and €31 000, respectively (table 3). Supplies 
were the major driver of costs each year. The greatest costs 
in 2014 were for latex gloves, glucometers and glucom-
eter strips; in 2015, they were for glucometers, strips and 
lancets (online supplement SM2). While medication costs 
increased in 2015 relative to 2014, staff costs remained 
unchanged and total costs decreased, largely driven 
by reduced excess consumption of latex gloves after it 
was identified as an issue during the IDP- OPD training 
sessions. The total number of patients and number of 
visits increased significantly from 2014 to 2015, rising 
from 77 and 626 to 144 and 1103, respectively. Thus, cost 
per- patient per- year (PPPY) dropped from €475 to €214 
and cost per- visit was halved from €58 to €28. This was 
due to the combined effect of higher patient numbers, 
greater total number of visits and lower supply costs in 
2015 compared with 2014 (online supplement SM2).
DiSCuSSiOn
This evaluation of a chronic disease programme in a 
complex conflict setting, using routine programmatic 
and cost data, provided lessons, which may improve 
clinical care and programme design. To the best of our 
knowledge, the influence of treatment interruption and 
insecurity on diabetes management in humanitarian 
settings has not been addressed in the literature. Simi-
larly, we are not aware of costing studies of diabetes care 
in crisis settings.
Our results show that glycaemic control was similar or 
better to that documented in other humanitarian or low- 
income settings (using different targets) and, while it was 
positively impacted by programmatic changes, control 
clearly deteriorated during periods of heightened inse-
curity.27 Our findings also indicate that, in a population 
previously undergoing regular supervision, a simplified 
nurse- provided, algorithm- driven service with consistent 
medication supply may be as effective as close medical 
supervision in maintaining disease control, particularly 
during periods of service interruption. Medical input 
could thus be focused on achieving glycaemic control in 
patients prescribed insulin, who appeared most affected 
by service interruption. We also note the lack of evidence 
supporting management of what we believed to be 
malnutrition- related diabetes.
Intermittent outbreaks of armed conflict limited 
patient access and disrupted supply chains, impeding 
continuity of care. We suggest that in high- insecurity 
settings, chronic disease programmes should focus on 
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Figure 2 Proportion of visits with BP or glycaemia at target by month, Mweso IDC- OPD service. BP, blood pressure; IDC- OPD, 
Integrated Diabetic Clinic within a Hospital Outpatient Department.
Table 3 Costs (€) of diabetes care in 2014 and 2015, 
Mweso IDC- OPD service
Cost category 2014
% 2014 
costs 2015
% 2015 
costs
Medicine costs 5 202 14 7746 25
Supply costs 25 435 70 17 180 56
Staff costs 5935 16 5935 19
Total costs 36 573 100 30 861 100
Costs per visit 58 28
Costs per patient 475 214
IDC- OPD, Integrated Diabetic Clinic within a Hospital Outpatient 
Department.
preparing patients, staff and supply chains to pre- empt 
treatment interruption during insecure periods, learning 
from HIV programme experiences in similar settings.28 
Preparation could include: triaging patients by vulner-
ability (eg, prioritising insulin- dependent diabetic 
patients, those with established complications and/or 
living far from the facility); enhancing patients’ health 
literacy and self- management education and provision of 
patient- held personal treatment plans and emergency kits 
(including several months’ supply of medications, such as 
insulin, delivery devices and guidance, as appropriate) to 
facilitate self- care during insecure periods; building staff 
capacity to allow for flexibility of roles in crises; estab-
lishing networks with other chronic disease programmes; 
and stockpiling and secure storage of medications.5 28 29 
Technology could facilitate continued patient treatment 
support when access to facilities is impossible, for example, 
via mobile phone short message service (SMS) messaging 
or decentralisation of care to community- based health 
workers furnished with clinical decision support tools or 
supported via telemedicine.
The relatively poorer glycaemic control in insulin- 
prescribed patients may reflect either disease severity or 
the challenges associated with insulin therapy. Adher-
ence to daily insulin injections is difficult anywhere; in 
Mweso, the security, financial and geographical barriers 
to accessing insulin and the unavailability, unaffordability 
and burden for families of the recommended diabetes 
diet, may additionally contribute to poor adherence.22 In 
this programme, clinicians adjusted insulin doses based 
on a single fasting glucose reading taken in clinic and 
on patients’ reported symptoms in the absence of home 
glucose monitoring and, therefore, dose adjustment was 
cautious and treatment targets were conservative.
There is limited, although growing, evidence on the 
incidence, prevalence and characterisation of diabetes 
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in sub- Saharan Africa, which our findings broadly 
reflect.30 Several reviews and recent ethnographic 
evidence describe ‘atypical’ forms of diabetes, which may 
complicate diagnosis, classification and management. 
These include ‘ketosis- prone atypical diabetes mellitus’ and 
‘malnutrition- related diabetes’.13 16 31 Local prevalence studies 
support the existence of the latter in the DRC, which 
is in keeping with the high proportion of underweight 
adults and ‘unclassified’ diabetics in our cohort.14 32 It 
is unclear whether malnutrition is causative, associated 
with hyperglycaemia or with pancreatic insufficiency and 
further study of diabetes epidemiology in DRC is needed, 
exploring factors such as childhood malnutrition, food 
insecurity and underweight and use of calorie- dense ther-
apeutic foods.31 Moreover, little evidence exists to guide 
either malnutrition- related diabetes care or the effective 
management of insulin in humanitarian settings, particu-
larly in the absence of home or community- based glucose 
testing.3 7
The total cost of care delivery decreased by 16% from 
2014 to 2015 despite increased visit and patient numbers. 
This was largely due to decreased supply costs, driven by 
the 100- fold reduction in consumption of latex gloves 
following IDC- OPD training. Efficiencies of supply 
consumption and patient throughput (more visits and 
more patients seen by the same number of staff) contrib-
uted to reducing PPPY costs by 55% from €475 in 2014 
to €214 in 2015.
To our knowledge, there is no available literature to 
compare cost per patient or per visit for diabetes care (or 
NCD care generally) delivered in unstable humanitarian 
settings. A study from Ghana reported a per patient 
annual direct cost of US$372.65 for hospital- delivered 
diabetes care in 2005. For a potential comparator, we 
looked at the cost of delivering chronic care for HIV, the 
main life- long condition with which humanitarian actors 
have traditionally engaged. The 2015 PPPY cost reported 
in this study is far lower than that reported by PEPFAR and 
others to deliver chronic HIV care programmes in LMICs 
in SSA.33 34 In terms of cost structure, supplies were the 
major cost driver in the Ghanaian study (syringes, lancets 
and strips), whereas other analyses of diabetes care in SSA 
identified medications, and specifically insulin, as the 
main cost contributor.35 36
Strengths and limitations
Using routine clinical and programmatic data, with 
minimal service disruption, we have explored clinical 
outcomes of a chronic disease programme in a protracted 
conflict setting and the influence of periods of height-
ened insecurity on intermediate clinical outcomes and 
on service delivery. Each patient who attended in a given 
month contributed data, irrespective of whether they 
ever experienced a treatment interruption. Our study 
provides new costing information for humanitarian 
actors to support the initiation or adaptation of specific 
NCD programmes and may potentially support scale up 
of similar services in DRC (and other conflict- affected 
settings). We concluded that the incremental cost of 
adding an outpatient diabetes service to a humanitarian 
health programme in a rural hospital setting may be 
achieved at a cost similar to that of delivering chronic 
HIV programmes. While we cannot confirm whether an 
external audit of cost data had taken place, we are confi-
dent in the quality of these data due to MSF’s robust 
systems and oversight by strong in- country and interna-
tional teams.
Given the logistical and ethical challenges of under-
taking research in conflict settings, we acknowledge that 
there are a number of study limitations. We had a relatively 
small sample size and no control group for comparison. 
We did not explore per patient control of clinical param-
eters over time, control by diabetes type (or age), appro-
priateness of prescribing, patient- reported outcomes or 
the influence of psychosocial factors, diet or adherence 
in each study phase since these data were unavailable. 
Gestational diabetes was not addressed since this was 
managed within antenatal services. Our costing analysis 
was descriptive so we could not comment on programme 
cost- effectiveness. Costing data were presented as average 
annual costs and did not explore the impact of various 
programme periods on costs. Since our cost data were 
aggregate, we could not explore patient- level costs or 
account for patient heterogeneity. While our findings 
may not be generalisable to other complex humanitarian 
settings or to other providers’ diabetes programmes in 
the DRC, our study contributes knowledge on key chal-
lenges and suggests solutions, which may be more broadly 
applicable.
Future research is needed in complex humanitarian 
settings to evaluate simplified, task- shared models of 
diabetes care, including culturally and contextually rele-
vant psychosocial support and dietary advice; to opti-
mise insulin management; and to evaluate emergency 
preparedness plans and technology- facilitated remote 
patient support.3 5 8 13 29 We recommend that future 
prospective studies should explore per- patient outcomes 
(while also examining programme- level outcomes as 
done in this study). We suggest including a control group; 
collecting additional outcome variables, such as compli-
cation rates and patient- reported outcomes, for example, 
quality- of- life, functionality and mental health outcomes; 
and exploring the impact of psychosocial stressors and 
treatment interruption on clinical outcomes. We also 
suggest that cost- effectiveness studies of different models 
of diabetes care, including use of technology- facilitated 
remote support, and patient level costing studies from 
both provider and patient perspectives should be under-
taken, exploring patient heterogeneity and direct and 
indirect patient costs.
COnCluSiOn
Our results help develop the sparse knowledge on the 
prevalence and characterisation of diabetes in sub- 
Saharan Africa. They demonstrate that diabetes care is 
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feasible even in complex humanitarian emergencies, and 
at a cost that is lower than chronic HIV care. The results 
also indicate that the Mweso IDC- OPD programme 
could be further simplified to involve drug collection 
along with nurse- led, algorithm- guided treatment adjust-
ment. We suggest that chronic disease programmes in 
unstable settings should engage in emergency prepared-
ness, learning from the experience of HIV programmes 
in similar settings. Future research is needed to eval-
uate simplified, task- shared models of diabetes care and 
management; and to evaluate emergency preparedness 
plans and technology- facilitated remote patient support.
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